Abstract
Fruits and vegetables have historically been considered rich sources of essential dietary micronutrients, soluble fiber, and antioxidants. More recently they are have been recognized as important sources for a wide array of phytochemicals that individually, or in combination, may benefit vascular health. Flavonoids are the largest, and most widely distributed class of phytochemicals, and can be further subdivided into several different sub-classes. Several epidemiology studies have observed an inverse association between flavonoid intake and risk of cardiovascular mortality. One sub-class of flavonoids, the flavanols, is found in foods such as grapes, red wine, tea, cocoa and chocolate; however, it is important to note that common food processing practices can significantly reduce the levels of these compounds found in finished food products. Recent studies have examined the potential of flavanol-rich cocoa and chocolates to influence vascular health. In this review, we discuss evidence for the hypothesis that the consumption of flavanol-rich cocoa can reduce the risk for cardiovascular disease through a multiplicity of mechanisms, including changes in oxidant defense mechanisms, vascular reactivity, cytokine production, and platelet function.
Similar content being viewed by others
References
Adamson GE, Lazarus SA, Mitchell AE, Prior RL, Cao G, Jacobs PH, Kremers BG, Hammerstone JF, Rucker RB, Ritter KA & Schmitz HH (1999) HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J. Agric. Food Chem. 47: 4184-4188.
Andriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet JC & Andriantsitohaina R (1998) Natural dietary polyphenolic compounds cause endotheliumdependent vasorelaxation in rat thoracic aorta. J. Nutr. 128: 2324-2333.
Arteel GE, Schroeder P & Sies H (2000) Reactions of peroxynitrite with cocoa procyanidin oligomers. J. Nutr. 130: 2100S-2104S.
Arteel GE & Sies H (1999) Protection against peroxynitrite by cocoa polyphenol oligomers. FEBS Lett. 462: 167-170.
Arts I, Hollman P, Feskens E, Bueno de Mesquita H & Kromhout D (2001) Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: The Zutphen Elderly Study. Am. J. Clin. Nutr. 74: 227-232.
Arts IC, Jacobs DR Jr., Gross M, Harnack LJ & Folsom AR (2002) Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control 13: 373-382.
Baba S, Osakabe N, Natsume M & Terao J (2002) Absorption and urinary excretion of procyanidin B2 [epicatechin-(4?-8)-epicatechin] in rats. Free Radic. Biol. Med. 33: 142-148.
Baba S, Osakabe N, Natsume M, Yasuda A, Takizawa T, Nakamura T & Terao J (2000a) Cocoa powder enhances the level of antioxidative activity in rat plasma. Br. J. Nutr. 84: 673-680.
Baba S, Osakabe N, Yasuda A, Natsume M, Takizawa T, Nakamura T & Terao J (2000b) Bioavailability of (-)-Epicatechin upon intake of chocolate and cocoa in human volunteers. Free Rad. Res. 33: 635-641.
Bhagwat S, Beecher GR, Haytowitz D, Holden J, Gebhardt S, Dwyer J, Peterson J & Eldridge A (2002) Development of a Database for Flavonoids in Foods. Poster presented at 26th National Nutrient Data Bank Conference. Baton Rouge, LA, USA.
Bearden MM, Pearson DA, Rein D, Chevaux KA, Carpenter DR, Keen CL & Schmitz H (2000) Potential cardiovascular health benefits of procyanidins present in chocolate and cocoa. In: Parliment TH, Ho C-T & Schieberle P (eds) Caffeinated Beverages: Health Benefits, Physiological Effects, and Chemistry. (pp. 177-186). American Chemical Society, Washington, DC.
Becker B, Heindl B, Kupatt C & Zahler S (2000) Endothelial function and hemostasis. Z. Kardiol. 89: 160-167.
Borchers A, Keen CL, Hannum S & Gershwin ME (2000) Cocoa and chocolate: Composition, bioavailability, and health implications. J. Med. Foods 3: 77-105.
Bordoni A, Hrelia S, Angeloni C, Giordano E, Guarnieri C, Caldarerea CM & Biagi PL (2002) Green tea protection of hypoxia/reoxygenation injury in cultured cardiac cells. J. Nutr. Biochem. 13: 103-111.
Bravo L (1998) Polyphenols: Chemistry, dietary sources, metabolism and nutritional significance. Nutr. Rev. 56: 317-333.
Brunet MJ, Blade C, Salvado MJ & Arola L (2002) Human apo A-I and rat transferrin are the principal plasma proteins that bind wine catechins. J. Agric. Food Chem. 50: 2708-2712.
Cai H & Harrison DG (2000) Endothelial dysfunction in cardiovascular disease. The role of oxidant stress. Circ. Res. 87: 840-844.
Cao Y, Cao R & Brakenhielm E (2002) Antiangiogenic mechanisms of diet-derived polyphenols. J. Nutr. Biochem. 13: 380-390.
Carr A, McCall MR & Frei B (2000) Oxidation of LDL by myeloperoxidase and reactive nitrogen species. Reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20: 1716-1723.
Chang W-C & Hsu F-L (1989) Inhibition of platelet aggregation and arachidonate metabolism in platelets by procyanidins. Prostaglandins Leukot Essent Fatty Acids 38: 181-188.
Chiu D, Lubin B & Shohet S (1982) Peroxidative reactions in red cell biology. In: Pryor W (ed) Free Radicals in Biology. Vol V. (pp. 115-160). Academic Press, New York.
Chow JM, Liu JC, Che YJ, Hsieh MH, Kao PF, Cheng JJ & Chan P (2002) The effects of catechin on superoxide dismutase activity and its gene expression in pheochromocytoma cells. Zhonghua Yi Xue Za Zhi (Taipei) 65: 138-143.
Colman RW, Clowes AW, George JN, Hirsch J & Marder VJ (2001) Overview of hemostasis. In: Colman RW, Hirsh J, Marder VJ, Clowes AW & George JN (eds) Hemostasis and thrombosis: basic principles and clinical practice. (pp. 3-16). Lippincott Williams & Wilkins, New York.
Dillinger TL, Barriga P, Escarcega S, Jimenez M, Lowe DS & Grivetti LE (2000) Food of the gods: Cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J. Nutr. 130: 2057S-2072S.
Donovan JL, Crespy V, Manach C, Morand C, Besson C, Scalbert A & Remesy C (2001) Catechin is metabolized by both the small intestine and liver of rats. J. Nutr. 131: 1753-1757.
Dusinska M, Vallova B, Ursinyova M, Hladikova V, Smolkova B, Wsolova L, Raslova K & Collins AR (2002) DNA damage and antioxidants; fluctuations through the year in a central European population group. Food Chem. Toxicol. 40: 1119-1123.
Farquharson CA, Butler R, Hill A, Belch JJ & Struthers AD (2002) Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106: 221-226.
Freedman JE, Parker III C, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD & Folts J (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103: 2792-2798.
Geleijnse JM, Launer LJ, Hofman A, Pols HA & Witteman JC (1999) Tea flavonoids may protect against atherosclerosis: The Rotterdam Study. Arch. Intern. Med. 159: 2170-2174.
Haslam E (1998) Practical polyphenolics: From structure to molecular recognition and physiological action. (pp. 178-225, 335-373). Cambridge University Press, New York.
Hannum SM & Erdman JJW (2000) Emerging health benefits from cocoa and chocolate. J. Med. Food 3: 73-75.
Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJ, Hollman PC & Katan MB (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med. 155: 381-386.
Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T & Chayama K (2002) Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346: 1954-1962.
Hiipakka RA, Zhang HZ, Dai W, Dai Q & Liao S (2002) Structure-activity relationships for inhibition of human 5-alpha-reductases by polyphenols. Biochem. Pharmacol. 63: 1165-1176.
Hollman PC (2001) Evidence for health benefits of plant phenols: local or systemic effects? J. Sci. Food Agric. 81: 842-852.
Holt RR, Lazarus SA, Sullards M, Zhu Q, Schramm DD, Hammerstone JF, Fraga CG, Schmitz H & Keen CL (2002a) Procyanidin dimer B2 (epicatechin-(4?-8)-epicatechin) in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76: 798-804.
Holt RR, Schramm DD, Keen CL, Lazarus SA & Schmitz H (2002b) Flavonoid-rich chocolate and platelet function. JAMA 287: 2212-2213.
Huang Y, Chan NW, Lau CW, Yao XQ, Chan FL & Chen ZY (1999) Involvement of endothelium/ nitric oxide in vasorelaxation induced by purified green tea (-)-epicatechin. Biochim. Biophys. Acta 1427: 322-328.
Hurst WJ, Tarka SM Jr., Powis TG, Valdez Jr. F & Hester TR (2002) Cacao usage by the earliest Maya civilization. Nature 418: 289-290.
Jimenez-Ramsey L, Rogler J, Housley T, Butler L & Elikin R (1994) Absorption and distribution of 14C-labeled condensed tannins and related sorghum phenolics in chickens. J. Agric. Food Chem. 42: 963-967.
Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE, Colditz G, Ascherio A, Rosner B, Spiegelman D & Willett WC (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med. 134: 1106-1114.
Karim M, McCormick K & Kappagoda CT (2000) Effects of cocoa procyanidins on endothelium-dependent relaxation. J. Nutr. 130: 2105S-2108S.
Kim H & Keeney P (1984) (-)-Epicatechin content in fermented and unfermented cocoa beans. J Food Sci 49: 1090-1092.
Kondo K, Hirano R, Matsumoto A, Igarashi O & Itakura H (1996) Inhibition of LDL oxidation by cocoa. Lancet 348: 1514.
Kris-Etherton P & Keen CL (2002) Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol. 13: 41-49.
Kuhnle G, Spencer JP, Schroeter H, Shenoy B, Debnam E, Srai SK, Rice-Evans C & Hahn U (2000) Epicatechin and catechin are omethylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun. 277: 507-512.
Lampe JW (1999) Health effects of vegetables and fruit: Assessing mechanisms of action in human experimental studies. Am. J. Clin. Nutr. 70: 475S-490S.
Laparra J, Michaud J & Masquelier J (1977) Etude pharmacocinetique des oligomeres flavanoliques. Plant Med. Phytother. 11: 133-142.
Lee M-J, Wang Z-Y, Li H, Chen L, Sun Y, Gobbo S, Balentine D & Yang CS (1995) Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epid. Biomar. Prev. 4: 393-399.
Libby P (2000) Changing concepts of atherogenesis. J. Int. Med. 247: 349-358.
Lotito SB, Actis-Goretta L, Renart L, Caligiuri M, Rein D, Schmitz HH, Steinberg FM, Keen CL & Fraga CG (2000) Influence of oligomer chain length on the antioxidant activity of procyanidins. Biochem. Biophys. Res. Commun. 276: 945-951.
Mao T, Powell J, Van de Water J, Keen CL, Schmitz H & Gershwin M (1999) The influence of cocoa procyanidins on the transcription of interleukin-2 in peripheral blood mononuclear cells. Int. J. Immunotherapy 15: 23-29.
Mao T, Powell J, Van De Water J, Keen CL, Schmitz H & Gershwin M (2000a) Effect of cocoa procyanidins on the secretion of interleukin-4 in peripheral blood mononuclear cells. J. Med. Food 3: 107-114.
Mao T, Powell J, Van DeWater J, Keen CL, Schmitz HH, Hammerstone JF & Gershwin ME (2000b) The effect of cocoa procyanidins on the transcription and secretion of interleukin 1 beta in peripheral blood mononuclear cells. Life Sci. 66: 1377-1386.
Mao T, Van De Water J, Keen CL, Schmitz H & Gershwin M (2000c) Cocoa procyanidins and human cytokine transcription and secretion. J. Nutr. 130: 2093S-2099S.
Miura Y, Chiba T, Miura S, Tomita I, Umegaki K, Ikeda M & Tomita T (2000) Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans. J. Nutr. Biochem. 11: 216-222.
Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K & Jaruga P (2002) Oxidative DNA damage: Assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic. Biol. Med. 33: 192-200.
Osakabe N, Baba S, Yasuda A, Iwamoto T, Kamiyama M, Takizawa T, Itakura H & Kondo K (2001) Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxdiation as demonstrated in healthy human volunteers. Free Rad. Res. 34: 93-99.
Osakabe N, Sanbongi C, Yamagishi M, Takizawa T & Osawa T (1998) Effects of polyphenol substances derived from Theobroma cacao on gastric mucosal lesion induced by ethanol. Biosci. Biotechnol. Biochem. 62: 1535-1538.
Ottavani JI, Carrasquedo F, Keen CL, Lazarus S, Schmitz HH & Fraga CG (2002) Influence of flavan-3-ols and procyanidins on UVC mediated formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine in isolated DNA. Arch. Biochem. Biophys. 406: 203-208.
Pearson D, Paglieroni T, Rein D, Wun T, Schramm DD, Wang JF, Holt RR, Gosselin R, Schmitz HH & Keen CL (2002) The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb. Res. 106: 191-197.
Pearson DA, Schmitz HH, Lazarus SA & Keen CL (2001) Inhibition of in vitro low-density lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. In: Packer L (ed) Methods in Enzymology. Vol 335: Flavonoids and Other Polyphenols. (pp. 350-360). Academic Press, New York.
Pietta P-G (2000) Flavonoids as antioxidants. J. Nat. Prod. 63: 1035-1042.
Pignatelli PP, Fabio M, Celestini A, Lenti L, Chiselli A, Gazzsaniga PP & Violi F (2000) The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am. J. Clin. Nutr. 72: 1150-1155.
Piskula MK & Terao J (1998) Accumulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J. Nutr. 128: 1172-1178.
Podrez EA, Abu-Soud HM & Hazen SL (2000) Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28: 1717-1725.
Porter LJ, Ma Z & Chan B (1991) Cacao procyanidins: Major flavanoids and identification of some minor metabolites. Phytochemistry 30: 1657-1663.
Puppo A & Halliwell B (1988) Formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Biochem. J. 249: 185-190.
Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z & Chesebro JH (2001) Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann. Intern. Med. 134: 224-238.
Rechner AR, Kuhnle G, Bremner P, Hubbard GP, Moore KP & Rice-Evans C (2002) The metabolic fate of dietary polyphenols in humans. Free Radic. Biol.Med. 33: 220-235.
Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH & Fraga CG (2000a) Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J. Nutr. 130: 2109S-2114S.
Rein D, Paglieroni TG, Wun T, Pearson DA, Schmitz HH, Gosselin R & Keen CL (2000b) Cocoa inhibits platelet activation and function. Am. J. Clin. Nutr. 72: 30-35.
Rice-Evans C (2001) Flavonoid antioxidants. Curr. Med. Chem. 8: 797-807.
Richelle M, Tavazzi I, Enslen M & Offord E (1999) Plasma kinetics in man of epicatechin from black chocolate. Eur. J. Clin. Nutr. 53: 22-26.
Richelle M, Tavazzi I & Offord E (2001) Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J. Agric. Food Chem. 49: 3438-3442.
Rios L, Bennett R, Lazarus S, Remesy C, Scalbert A & Williamson G (2002) Cocoa procyanidins are stable during gastric transit in humans. Am. J. Clin. Nutr. 76: 1106-1110.
Ross JA & Kasum CM (2002) Dietary flavonoids: Bioavailability, metabolic effects, and safety. Ann. Rev. Nutr. 22: 19-34.
Ross R (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340: 115-126.
Salucci M, Stivala LA, Maiani G, Bugianesi R & Vannini V (2002) Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br. J. Cancer 86: 1645-1651.
Sanbongi C, Osakabe N, Nausume M, Takizawa T, Gomi S & Osawa T (1998) Antioxidative polyphenols isolated from theobroma cacao. J. Agric. Food Chem. 46: 454-457.
Sanbongi C, Suzuki N & Sakane T (1997) Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunolog. 177: 129-136.
Satoh K, Sakamoto Y, Ogata A, Nagai F, Mikuriya H, Numazawa M, Yamada K & Aoki N (2002) Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem. Toxicol. 40: 925-933.
Schewe T, Kuhn H & Sies H (2002) Flavonoids of cocoa inhibit recombinant human 5-lipoxygenase. J. Nutr. 132: 1825-1829.
Schewe T, Sadik C, Klotz L-O, Yoshimoto T, Kuhn H & Sies H (2001) Polyphenols of cocoa: Inhibition of mammalian 15-lipoxygenase. Biol. Chem. 382: 1687-1696.
Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SL, Schmitz HH, German JB & Keen CL (2001) Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am. J. Clin. Nutr. 73: 36-40.
ShinWS, Szuba A & Rockson SG (2002) The role of chemokines in human cardiovascular pathology: Enhanced biological insights. Atherosclerosis 160: 91-102.
Spencer JP, Chaudry F, Pannala AS, Srai SK, Debnam E & Rice-Evans C (2000) Decomposition of cocoa procyanidins in the gastric milieu. Biochem. Biophys. Res. Commun. 272: 236-241.
Spencer JP, Schroeter H, Shenoy B, Srai SK, Debnam E & Rice-Evans C (2001) Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem. Biophys. Res. Commun. 285: 588-593.
Steinberg FM, Holt RR, Schmitz HH & Keen CL (2002) Cocoa procyanidin chain length does not determine ability to protect LDL from oxidation when monomer units are controlled. J. Nutr. Biochem. (in press).
Stevens JF, Miranda CL, Wolthers KR, Schimerlik M, Deinzer ML & Buhler DR (2002) Identification and in vitro biological activities of hop proanthocyanidins: Inhibition of nNOS activity and scavenging of reactive nitrogen species. J. Agric. Food Chem. 50: 3435-3443.
Tang FY & Meydani M (2001) Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production. Nutr. Cancer 41: 119-125.
Tribble DL (1999) Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and B-carotene. A statement for healthcare professionals from the American Heart Association. Circulation 99: 591-595.
Vanhoutte P-M, Boulanger C-M & Mombouli J-V (1995) Endothelium-derived relaxing factors and converting enzyme inhibition. Am. J. Cardio. 76: 3E-12E.
Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus S & Kris-Etherton P (2001) Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am. J. Clin. Nutr. 74: 596-602.
Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmitz HH & Keen CL (2000) A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr. 130: 2115S-2119S.
Warden BA, Smith LS, Beecher GR, Balentine D & Clevidence BA (2001) Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 131: 1731-1737.
Waterhouse AL, Shirley JR & Donovan JL (1996) Antioxidants in chocolate. Lancet 348: 834.
Youdim KA, McDonald J, Kalt W & Joseph JA (2002) Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J. Nutr. Biochem. 13: 282-288.
Zhu Q, Holt R, Lazarus S, Ensunsa J, Hammerstone J, Schmitz H & Keen C (2002a) Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa. J. Agric. Food Chem. 50: 1700-1705.
Zhu Q, Holt R, Lazarus S, Orozco T & Keen C (2002b) Inhibitory effects of cocoa flavanols and procyanidin oligomers on free radical-induced erythrocyte hemolysis. Exp. Biol. Med. 227: 321-329.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Keen, C.L., Holt, R.R., Polagruto, J.A. et al. Cocoa flavanols and cardiovascular health. Phytochemistry Reviews 1, 231–240 (2002). https://doi.org/10.1023/A:1022519719938
Issue Date:
DOI: https://doi.org/10.1023/A:1022519719938